Development of NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitorKIMURA, Shinya; NIWA, Tomoko; HIRABAYASHI, Kazuko et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s55-s61, SUP1Conference Paper

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemiaKIMURA, Shinya; NAITO, Haruna; NAKAYA, Yohei et al.Blood. 2005, Vol 106, Num 12, pp 3948-3954, issn 0006-4971, 7 p.Article

Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancerYANO, Junichi; HIRABAYASHI, Kazuko; IRIMURA, Tatsuro et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7721-7726, issn 1078-0432, 6 p.Article